ReShape Lifesciences provides $400k loan to Vyome, extends merger deadline to June 30

Vyome Holdings, Inc

ReShape loans Vyome up to $400k in three tranches at 8% interest, due Sept 30, 2025.
Merger termination date extended from March 31 to June 30, 2025.
Termination fee reduced to $1M minus outstanding note amounts if ReShape terminates.
Note becomes senior secured if merger fails due to concurrent financing default.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.